智慧门急诊药房产品

Search documents
艾隆科技股价跌5.14%,大成基金旗下1只基金位居十大流通股东,持有82.83万股浮亏损失90.28万元
Xin Lang Cai Jing· 2025-09-23 02:53
大成中证360互联网+指数A(002236)成立日期2016年2月3日,最新规模6.98亿。今年以来收益 34.45%,同类排名1422/4220;近一年收益90.82%,同类排名730/3814;成立以来收益217.1%。 大成中证360互联网+指数A(002236)基金经理为夏高。 9月23日,艾隆科技跌5.14%,截至发稿,报20.13元/股,成交3768.19万元,换手率2.35%,总市值15.54 亿元。 资料显示,苏州艾隆科技股份有限公司位于中国(江苏)自由贸易试验区苏州片区苏州工业园区新庆路71 号,成立日期2006年1月20日,上市日期2021年3月29日,公司主营业务涉及公司专注于医疗物资的智能 管理领域,通过打造医疗物资智能管理设备及软件信息平台,为各级医疗服务机构提供医疗物资智能化管 理整体解决方案。主营业务收入构成为:智慧门急诊药房产品43.34%,维保16.55%,住院、静配中心 产品16.03%,其他(补充)8.27%,智能仓储产品7.83%,药事(学)信息化产品3.84%,病区(麻醉/精)药品 管理产品3.48%,其他0.35%,中药智能化产品0.32%。 从艾隆科技十大流通股东 ...
艾隆科技股价跌5.05%,大成基金旗下1只基金位居十大流通股东,持有82.83万股浮亏损失90.28万元
Xin Lang Cai Jing· 2025-08-28 06:21
Group 1 - The core viewpoint of the news is that Ailong Technology's stock has experienced a decline of 5.05%, with a current price of 20.50 yuan per share and a total market capitalization of 1.583 billion yuan [1] - Ailong Technology, established on January 20, 2006, focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for medical institutions [1] - The company's main revenue sources include smart emergency pharmacy products (43.34%), maintenance services (16.55%), inpatient and infusion center products (16.03%), and other categories [1] Group 2 - Among Ailong Technology's top circulating shareholders, Dacheng Fund's index fund has entered the top ten, holding 828,300 shares, which is 1.07% of the circulating shares [2] - The Dacheng CSI 360 Internet + Index A fund has achieved a year-to-date return of 34.52% and a one-year return of 94.57% [2] - The fund manager, Xia Gao, has a tenure of 10 years and has managed a total fund size of 2.26 billion yuan, with the best return during his tenure being 217.27% [3]
艾隆科技8月26日获融资买入486.49万元,融资余额6860.95万元
Xin Lang Cai Jing· 2025-08-27 02:13
Group 1 - The core business of Ailong Technology focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for medical institutions [2] - As of August 8, 2025, the number of shareholders in Ailong Technology increased by 3.45% to 4,711, while the average circulating shares per person decreased by 3.33% to 16,387 shares [2] - For the first half of 2025, Ailong Technology reported a revenue of 131 million yuan, a year-on-year decrease of 8.11%, and a net profit attributable to shareholders of -8.39 million yuan, an increase of 55.47% year-on-year [2] Group 2 - Ailong Technology has distributed a total of 111 million yuan in dividends since its A-share listing, with 49.05 million yuan distributed over the past three years [3] - As of June 30, 2025, the sixth largest circulating shareholder of Ailong Technology is Dazheng Zhongzheng 360 Internet+ Index A, holding 828,300 shares as a new shareholder [3] Group 3 - On August 26, Ailong Technology's stock price increased by 0.40%, with a trading volume of 41.91 million yuan [1] - The financing buy-in amount for Ailong Technology on August 26 was 4.86 million yuan, with a net financing buy-in of 643,800 yuan, while the total financing and securities balance reached 68.61 million yuan, accounting for 3.92% of the circulating market value [1] - The securities lending data for Ailong Technology on August 26 showed no shares were lent or repaid, indicating a high level of securities lending balance at 0.00 shares, which is above the 90th percentile over the past year [1]